Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Allergy Clin Immunol ; 136(3): 581-587.e2, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26115906

RESUMEN

BACKGROUND: Early term-born (37-38 weeks' gestation) infants have increased respiratory morbidity during the neonatal period compared with full term-born (39-42 weeks' gestation) infants, but longer-term respiratory morbidity remains unclear. OBJECTIVE: We assessed whether early term-born children have greater respiratory symptoms and health care use in childhood compared with full term-born children. METHODS: We surveyed 1- to 10-year-old term-born children (n = 13,361). Questionnaires assessed respiratory outcomes with additional data gathered from national health databases. RESULTS: Of 2,845 eligible participants, 545 were early term-born and 2,300 were full term-born. Early term-born children had higher rates of admission to the neonatal unit (odds ratio [OR], 1.7; 95% CI, 1.2-2.5) and admission to the hospital during their first year of life (OR, 1.6; 95% CI, 1.2-2.1). Forty-eight percent of early term-born children less than 5 years old reported wheeze ever compared with 39% of full term-born children (OR, 1.5; 95% CI, 1.1-1.9), and 26% versus 17% reported recent wheezing (OR, 1.7; 95% CI, 1.3-2.4). Early term-born children older than 5 years reported higher rates of wheeze ever (OR, 1.4; 95% CI, 1.05-1.8) and recent wheezing over the last 12 months than full-term control subjects (OR, 1.4; 95% CI, 1.02-2.0). Increased rates of respiratory symptoms in early term-born children persisted when family history of atopy and delivery by means of cesarean sections were included in logistic regression models. CONCLUSION: Early term-born children had significantly increased respiratory morbidity and use of health care services when compared with full term-born children, even when stratified by mode of delivery and family history of atopy.


Asunto(s)
Edad Gestacional , Hospitalización/estadística & datos numéricos , Ruidos Respiratorios/diagnóstico , Cesárea/estadística & datos numéricos , Niño , Preescolar , Estudios Transversales , Salud de la Familia/estadística & datos numéricos , Femenino , Humanos , Lactante , Masculino , Embarazo , Ruidos Respiratorios/fisiopatología , Factores de Riesgo , Nacimiento a Término
2.
Artículo en Inglés | MEDLINE | ID: mdl-33801485

RESUMEN

Childhood overweight and obesity is a worldwide public health issue. Our objective was to describe planned, ongoing and completed randomized controlled trials (RCTs) designed for the prevention of obesity in early childhood. Two databases (World Health Organization International Clinical Trials Registry Platform, ClinicalTrials.gov) were searched to identify RCTs with the primary aim of preventing childhood obesity and at least one outcome related to child weight. Interventions needed to start in the first two years of childhood or earlier, continue for at least 6 months postnatally, include a component related to lifestyle or behaviours, and have a follow up time of at least 2 years. We identified 29 unique RCTs, implemented since 2008, with most being undertaken in high income countries. Interventions ranged from advice on diet, activity, sleep, emotion regulation, and parenting education through to individual home visits, clinic-based consultations, or group education sessions. Eleven trials published data on child weight-related outcomes to date, though most were not sufficiently powered to detect significant effects. Many trials detected improvements in practices such as breastfeeding, screen time, and physical activity in the intervention groups compared to the control groups. Further follow-up of ongoing trials is needed to assess longer-term effects.


Asunto(s)
Obesidad Infantil , Peso Corporal , Niño , Preescolar , Dieta , Ejercicio Físico , Femenino , Humanos , Lactante , Obesidad Infantil/prevención & control , Ensayos Clínicos Controlados Aleatorios como Asunto
3.
Nurs Stand ; 31(42): 32, 2017 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-28610531

RESUMEN

Patient information is meant to be confidential. How is that possible when you give a bedside handover with other patients in the room (Readers' Panel, June 7). Handovers should be done in the office, followed by a walk around to introduce yourself as the nurse taking over the care, and to check on any infusions.

4.
PLoS One ; 11(5): e0155695, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27203564

RESUMEN

INTRODUCTION: Although preterm birth is associated with respiratory morbidity in childhood, the role of family history of atopy and whether appropriate treatment has been instituted is unclear. Thus we assessed (i) the prevalence of respiratory symptoms, particularly wheezing, in childhood; (ii) evaluated the role of family history of atopy and mode of delivery, and (iii) documented the drug usage, all in preterm-born children compared to term-born control children. METHODS: We conducted a cross-sectional population-based questionnaire study of 1-10 year-old preterm-born children (n = 13,361) and matched term-born controls (13,361). Data (n = 7,149) was analysed by gestational groups (24-32 weeks, 33-34 weeks, 35-36 weeks and 37-43 weeks) and by age, <5 years old or ≥ 5 years. MAIN RESULTS: Preterm born children aged <5 years (n = 2,111, term n = 1,402) had higher rates of wheeze-ever [odds ratio: 2.7 (95% confidence intervals 2.2, 3.3); 1.8 (1.5, 2.2); 1.5 (1.3, 1.8) respectively for the 24-32 weeks, 33-34 weeks, 35-36 weeks groups compared to term]. Similarly for the ≥5 year age group (n = 2,083, term n = 1,456) wheezing increased with increasing prematurity [odds ratios 3.3 (2.7, 4.1), 1.8 (1.5, 2.3) and 1.6 (1.3, 1.9) for the three preterm groups compared to term]. At both age groups, inhaler usage was greater in the lowest preterm group but prematurity-associated wheeze was independent of a family history of atopy. CONCLUSIONS: Increasing prematurity was associated with increased respiratory symptoms, which were independent of a family history of atopy. Use of bronchodilators was also increased in the preterm groups but its efficacy needs careful evaluation.


Asunto(s)
Hipersensibilidad Inmediata/epidemiología , Ruidos Respiratorios/fisiopatología , Niño , Preescolar , Estudios Transversales , Femenino , Edad Gestacional , Humanos , Hipersensibilidad Inmediata/etiología , Hipersensibilidad Inmediata/fisiopatología , Lactante , Recién Nacido , Recien Nacido Prematuro/fisiología , Enfermedades del Prematuro/epidemiología , Masculino , Oportunidad Relativa , Embarazo , Nacimiento Prematuro/fisiopatología , Prevalencia , Factores de Riesgo , Encuestas y Cuestionarios
5.
Ann N Y Acad Sci ; 966: 456-63, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12114304

RESUMEN

Endomorphin (EM)-1 and EM-2 are tetrapeptides with high affinity and selectivity for the micro-opioid receptor. We have utilized specific radioimmunoassays to characterize EM-1 and EM-2 in immune tissues from normal human subjects and from rats with adjuvant arthritis (AA). PBLs from three normal human subjects contained 248, 13, and 303 pg EM-1 per 100 million cells, whereas EM-2 was measured in two subjects at 69 and 588 pg per 100 million cells. In AA rats, EM-1 (but not EM-2) contents in the spleen and thymus were elevated compared with levels in tissues from non-AA controls. EM-1 was detectable in five of eight samples of synovial tissue from inflamed hind paws, whereas EM-2 was detectable in two of eight synovial extracts. Neither EM-1 nor EM-2 were detectable in synovial tissue from non-AA rats. To our knowledge, this is the first report of endomorphins in normal human immune cells. Increased endomorphin expression or uptake in peripheral tissues in a rodent model of chronic inflammation provides potential for endomorphins to selectively modulate chronic inflammation in mammals.


Asunto(s)
Artritis Experimental/inmunología , Subgrupos Linfocitarios/química , Oligopéptidos/análisis , Animales , Apoptosis/efectos de los fármacos , Artritis Experimental/metabolismo , Concanavalina A/farmacología , Humanos , Lipopolisacáridos/farmacología , Activación de Linfocitos/efectos de los fármacos , Subgrupos Linfocitarios/efectos de los fármacos , Masculino , Morfina/farmacología , Oligopéptidos/farmacología , Radioinmunoensayo , Ratas , Ratas Wistar , Bazo/química , Líquido Sinovial/química , Timo/química
6.
Clin Child Psychol Psychiatry ; 18(4): 483-503, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23104966

RESUMEN

The role of psychosocial factors in perpetuating and predisposing towards the development of attention deficit hyperactivity disorder (ADHD) symptoms has been neglected within the field of child mental health. Clinicians, when told that a child had a diagnosis of ADHD, have been found to underestimate the presence of psychosocial factors, and are less likely to ask about the possibility of neglect or abuse. This article details the considerable research showing links between ADHD symptoms and parental mental illness, child maltreatment, post-traumatic stress disorder (PTSD), attachment disorders and other environmental factors. Recent neuro-biological findings showing the impact on brain development of early abuse and attachment concerns are cited. The implications of these findings both for clinicians, and at policy level, are discussed, and the reasons underlying the need for a more integrated Bio-Psycho-Social approach to ADHD are outlined.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Maltrato a los Niños/psicología , Hijo de Padres Discapacitados/psicología , Trastorno por Déficit de Atención con Hiperactividad/etiología , Trastorno por Déficit de Atención con Hiperactividad/psicología , Niño , Humanos , Padres/psicología , Trastorno de Vinculación Reactiva/complicaciones , Trastorno de Vinculación Reactiva/diagnóstico , Trastorno de Vinculación Reactiva/psicología , Trastornos por Estrés Postraumático/complicaciones , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/psicología
8.
PLoS One ; 6(8): e23423, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21853131

RESUMEN

Following injury, dorsal root ganglion (DRG) neurons undergo transcriptional changes so as to adopt phenotypic changes that promote cell survival and axonal regeneration. Here we used a microarray approach to profile changes in a population of small noncoding RNAs known as microRNAs (miRNAs) in the L4 and L5 DRG following sciatic nerve transection. Results showed that 20 miRNA transcripts displayed a significant change in expression levels, with 8 miRNAs transcripts being altered by more than 1.5-fold. Using quantitative reverse transcription PCR, we demonstrated that one of these miRNAs, miR-21, was upregulated by 7-fold in the DRG at 7 days post-axotomy. In dissociated adult rat DRG neurons lentiviral vector-mediated overexpression of miR-21 promoted neurite outgrowth on a reduced laminin substrate. miR-21 directly downregulated expression of Sprouty2 protein, as confirmed by Western blot analysis and 3' untranslated region (UTR) luciferase assays. Our data show that miR-21 is an axotomy-induced miRNA that enhances axon growth, and suggest that miRNAs are important players in regulating growth pathways following peripheral nerve injury.


Asunto(s)
Envejecimiento/metabolismo , Axones/metabolismo , Axotomía , Ganglios Espinales/metabolismo , MicroARNs/metabolismo , Proteínas Adaptadoras Transductoras de Señales , Animales , Perfilación de la Expresión Génica , Péptidos y Proteínas de Señalización Intracelular , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos C57BL , MicroARNs/genética , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Neuritas/metabolismo , Neuritas/patología , Proteínas Serina-Treonina Quinasas , Ratas , Ratas Wistar , Nervio Ciático/lesiones , Nervio Ciático/metabolismo , Nervio Ciático/patología , Regulación hacia Arriba/genética
10.
Ann N Y Acad Sci ; 1193: 117-22, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20398016

RESUMEN

The opioid tetrapeptides endomorphins (EM)-1 and EM-2 are widely expressed in central nervous system and immune tissues of rats and humans. Their analgesic properties are well characterized but they also have anti-inflammatory properties. EM-1 significantly attenuated the onset of hindpaw inflammation in adjuvant-induced arthritis in rats. Immunohistochemical staining demonstrated the presence of EMs in T cells, macrophages, and fibroblasts in synovial tissues from patients with osteo- or rheumatoid arthritis (RA). In an ex vivo superfusion system, EM-1 potently inhibited the release of proinflammatory cytokines interleukin (IL)-6 and IL-8 from synovial tissues from patients with osteo- or RA. These results demonstrate that EMs are endogenously synthesized within human immune cells and have the potential to act as potent therapeutic agents in the treatment of chronic inflammatory disease. We discuss the clinical potential for EM analogues chemically modified to resist proteolytic degradation and identify modified protease-resistant analogues with enhanced bioactivity.


Asunto(s)
Artritis Experimental/inmunología , Artritis Reumatoide/inmunología , Oligopéptidos/inmunología , Osteoartritis/inmunología , Animales , Artritis Experimental/metabolismo , Artritis Reumatoide/metabolismo , Humanos , Oligopéptidos/metabolismo , Osteoartritis/metabolismo , Ratas
11.
Child Adolesc Ment Health ; 9(3): 144, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32797487
13.
Arthritis Rheum ; 58(2): 456-66, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18240240

RESUMEN

OBJECTIVE: Pain sensitization and the related secretion of neuropeptides from sensory nerve terminals are proinflammatory in osteoarthritis (OA), rheumatoid arthritis (RA), and adjuvant-induced polyarthritis. In contrast, endogenous opioids such as the recently discovered endomorphins (EMs) are antiinflammatory. However, the role of endogenous EMs such as EM-1 and EM-2 has never been investigated in OA and RA. METHODS: We established a highly sensitive radioimmunoassay to detect EM-1 and EM-2. In patients with RA and patients with OA, immunohistochemistry for EM-1 and EM-2 was performed, and double-staining was used to identify EM-positive cells. The effects of EM-1 and EM-2 on the secretion of interleukin-6 (IL-6) and IL-8 from human synovial tissue were studied by tissue superfusion, and the therapeutic effects of EM-1 were tested in a rat model of adjuvant-induced polyarthritis. RESULTS: EM-positive cells were located in the sublining area and vessel walls but were particularly evident in the highly inflamed lining area. Human macrophages, T cells, and fibroblasts stained positive for EMs. The synovial density of EM-positive cells was higher in patients with OA than in those with RA. EM-1 inhibited synovial secretion of IL-6 in patients with RA and secretion of IL-8 in patients with RA and those with OA (maximum 10(-10)M). EM-2 inhibited IL-8 secretion only from RA tissue (maximum 10(-10)M). In rats with adjuvant-induced polyarthritis, thymus, spleen, and synovial tissue contained significantly more EM-1 than was observed in controls. Rats with adjuvant-induced polyarthritis benefited from EM-1 treatment. CONCLUSION: EM-1 had antiinflammatory effects in patients with OA or RA and in a model of adjuvant-induced polyarthritis. Local enhancement of EM-1 might be an interesting therapeutic option in different forms of arthritis.


Asunto(s)
Artritis/inmunología , Oligopéptidos/inmunología , Anciano , Artritis Experimental/inmunología , Artritis Reumatoide/inmunología , Femenino , Humanos , Inmunohistoquímica , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Masculino , Persona de Mediana Edad , Oligopéptidos/metabolismo , Osteoartritis/inmunología , Membrana Sinovial/inmunología , Membrana Sinovial/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA